
Moberg Pharma AB (publ): directors' dealings · Finland · FIN-FSA
FI:moberg-pharma-ab-publSE0020353928FIFI·FIN-FSAMcap 503M€Healthcare
Explore the full management transaction log of Moberg Pharma AB (publ), a listed issuer based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Moberg Pharma AB (publ) has published 3 insider filings. Market capitalisation: €502.9m. The latest transaction was filed on 25 June 2025 — Purchase. Among the most active insiders: Richard Ding. All data is free.
Financial data
FY ended December 2025 · cache
Analyst consensus
1 analysts14.00 €Target 14.00 €(+31%)14.00 €
Income statement
Revenue13.5 M€
Gross profit7.7 M€57% margin
Net income−27.2 M€-201.2% margin
Valuation
PER (forward)53.5x
P/Book0.5x
Beta0.64
Balance sheet & cash
Market cap502.9 M€
Total debt2.5 M€
Free Cash Flow−60.7 M€
Debt / Equity2%
Profitability & ownership
% insiders12.1%
% institutions21.7%
Last declaration on 25 June 2025